Dyslipidemia in retinal metabolic disorders

Author:

Fu Zhongjie12ORCID,Chen Chuck T3,Cagnone Gael45,Heckel Emilie45,Sun Ye1,Cakir Bertan1,Tomita Yohei1,Huang Shuo1,Li Qian6,Britton William1,Cho Steve S1,Kern Timothy S7,Hellström Ann8,Joyal Jean‐Sébastien45,Smith Lois EH1ORCID

Affiliation:

1. Department of Ophthalmology Harvard Medical School Boston Children's Hospital Boston MA USA

2. Manton Center for Orphan Disease Harvard Medical School Boston Children's Hospital Boston MA USA

3. National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Bethesda MD USA

4. Department of Pediatrics, Pharmacology and Ophthalmology CHU Sainte‐Justine Research Center Université de Montréal Montreal QC Canada

5. Department of Pharmacology and Therapeutics University of Montreal Montreal QC Canada

6. Beijing Tongren Eye Center Beijing Tongren Hospital Capital Medical University Beijing China

7. Center for Translational Vision Research Gavin Herbert Eye Institute Irvine CA USA

8. Section for Ophthalmology Department of Clinical Neuroscience Institute of Neuroscience and Physiology Sahlgrenska Academy University of Gothenburg Göteborg Sweden

Funder

National Eye Institute

Boston Children's Hospital

Manton Center for Orphan Disease Research, Boston Children's Hospital

Deutsche Forschungsgemeinschaft

Manpei Suzuki Diabetes Foundation

Natural Science Foundation of Beijing Municipality

European Commission

Svenska Forskningsrådet Formas

National Institutes of Health

Publisher

EMBO

Subject

Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3